Lord, Abbett & Co
NPCE icon

Lord, Abbett & Co’s Neuropace NPCE Stock Holding History

Lord, Abbett & Co’s Portfolio NPCE Stock Details NPCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-400,743
Closed -$4.46M – 569
2025
Q2 		$4.46M Sell
400,743
-65,272
-14% -$816K 0.01% 470
2025
Q1 		$5.73M Buy
+466,015
New +$5.83M 0.02% 443
2022
Q1 		– Sell
-355,972
Closed -$3.59M – 662
2021
Q4 		$3.59M Sell
355,972
-3,449
-1% -$44.8K 0.01% 571
2021
Q3 		$5.7M Buy
359,421
+112,053
+45% +$2.35M 0.01% 582
2021
Q2 		$5.88M Buy
+247,368
New +$5.74M 0.01% 600

Other funds holding NPCE

PCH
Polar Capital Holdings London, United Kingdom $22.9B AUM 115.26% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
AC
Armistice Capital New York $3.03B AUM 36.06% 1-Year Est. Return
KLP
Kent Lake PR Anasco, Puerto Rico $195M AUM 5.21% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return